Workflow
IceCure's ProSense® Featured at CIRSE 2025 Annual Meeting: Positive Clinical Results with Cryoablation from 4 Independent Studies Presented
IceCureIceCure(US:ICCM) Prnewswire·2025-09-22 12:30

Accessibility StatementSkip Navigation Presentations from 5 Key Opinion Leaders on ProSense® cryoablation including 3 independent studies on breast cancer and 1 on endometriosis   3 hands-on training sessions for doctors interested in using ProSense® were very well attended Dedicated CIRSE focus session on the breast shows the growing interest from interventional radiologists to expand their practice to include care for breast cancer patients CAESAREA, Israel, Sept. 22, 2025 /PRNewswire/ -- IceCure Medic ...